ClinicalTrials.gov
ClinicalTrials.gov Menu

A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00937352
Recruitment Status : Terminated
First Posted : July 13, 2009
Last Update Posted : December 20, 2013
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : September 2012
  Actual Study Completion Date : September 2012
  Certification/Extension First Submitted : October 30, 2013